Revolution Medicines, Inc. (RVMD)
96.45
+0.93
(+0.97%)
USD |
NASDAQ |
Mar 25, 11:20
Revolution Medicines EPS Diluted (Quarterly) : -1.855 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Merck & Co., Inc. | 1.191 |
| AbbVie, Inc. | 1.018 |
| Tango Therapeutics, Inc. | -0.2945 |
| Insmed, Inc. | -1.538 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -364.89M |
| Total Expenses (Quarterly) | 364.89M |
| Enterprise Value | 17.33B |
| Earnings Yield | -6.13% |
| Normalized Earnings Yield | -6.077 |